SCHEMBL29909003

SCHEMBL29909003

Cc1ccc(-c2cccc(N(C)c3nc4nncn4c4cc([N+](=O)[O-])ccc34)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 2/20 0.45
▸ MEN1 O00255 3/20 0.36
▸ NPC1 O15118 3/20 0.36
▸ MAPT P10636 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ NPBWR1 P48145 2/20 0.36
▸ NFKB1 P19838 2/20 0.36
▸ NFKB2 Q00653 2/20 0.36
▸ RELA Q04206 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ HRH4 Q9H3N8 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ MMP2 P08253 1/20 0.34
▸ MMP9 P14780 1/20 0.34
▸ MMP8 P22894 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23578021 1.00 ABCG2 (0.45) ABCG2MEN1NPC1MAPTRAB9A
SCHEMBL29909184 0.94 ABCG2 (0.52) ABCG2MAPTNPBWR1ALDH1A1HTT
SCHEMBL23576737 0.94 ABCG2 (0.52) ABCG2MAPTNPBWR1ALDH1A1HTT
SCHEMBL29909490 0.92 ABCG2 (0.44) ABCG2SMN1; SMN2ALDH1A1HRH4HRH3
SCHEMBL23576891 0.92 ABCG2 (0.44) ABCG2SMN1; SMN2ALDH1A1HRH4HRH3
SCHEMBL23577259 0.90 ABCG2 (0.43) ABCG2MEN1NPC1MAPTRAB9A
SCHEMBL29909220 0.90 ABCG2 (0.43) ABCG2MEN1NPC1MAPTRAB9A
SCHEMBL23601765 0.90 ABCG2 (0.44) ABCG2MEN1NPC1MAPTRAB9A
SCHEMBL31169388 0.88 ABCG2 (0.40) ABCG2MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL24721427 0.87 ABCG2 (0.41) ABCG2MEN1MAPTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4445902-A2 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS Carna Biosciences, Inc. (JP) 2024-10-16 — — EP disclosed
EP-4081305-B1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS CARNA BIOSCIENCES INC (JP) 2024-09-18 — — EP disclosed
US-12054490-B2 Diacylglycerol kinase modulating compounds GILEAD SCIENCES, INC. (US) 2024-08-06 — — US disclosed
EP-4081305-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS Carna Biosciences, Inc. (JP) 2022-11-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12054490-B2 Diacylglycerol kinase modulating compounds DGKG, DGKB, DGKK ABCG2 4216/4885MEN1 4106/4885NPC1 991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback